Advertisement

Russia is developing Russia is developing insulin in tablet form as an alternative to injections for treating diabetes patients in tablet form as an alternative to injections for treating diabetes patients

Russia is developing   Russia is developing insulin in tablet form as an alternative to injections for treating diabetes patients in tablet form as an alternative to injections for treating diabetes patients

Russian specialists, in collaboration with their pharmaceutical partners, are working on developing types of insulin in tablet form, according to Natalia Mokresheva, head of the Dedov Medical Research and Endocrinology Center.

Hot Topics

According to Natalia Mokresheva, this refers to oral insulin , meaning insulin taken by mouth instead of being injected. She added, "Long-acting insulins have also been developed, and once-weekly injections may become possible in the near future."

The expert explained that these recent developments aim to make life easier for diabetic patients, noting that innovative treatment methods help control the disease and reduce its impact on the lives of those affected.

She pointed out that the development of oral insulin is still in the approval stage and that it is not yet a widely available medication in pharmacies. The main scientific challenge lies in protecting insulin from breakdown within the digestive system and ensuring its effective delivery to the bloodstream.

It is worth noting that manufacturing insulin tablets is no easy task, as the drug, once swallowed, passes through the entire digestive system, where hydrochloric acid in the stomach and digestive enzymes can break down the protein. Therefore, scientists are striving to find a way to protect insulin molecules and ensure the gradual release of the active ingredient in the intestines.

In the search for promising solutions, researchers are exploring the use of chitosan-based nanoparticles, a non-toxic substance extracted from the shells of crustaceans and insects. These nanoparticles can perform two main functions:

Protecting insulin from breakdown within the digestive system.

Adheres to mucous membranes and releases the drug gradually, thanks to its muco-adherence properties.

In 2021, scientists from Russia’s Lobachevsky University obtained a patent for a nano-formulation of this type, intended for oral insulin delivery.

Diabetes is usually divided into two main types, type 1 and type 2, but diabetes specialists also distinguish four forms of the disease, one of which is LADA, or latent autoimmune diabetes in adults.

This form is essentially a type of adult-onset diabetes that develops after the age of 30. It is characterized by its difficulty in detection, as it may remain undiagnosed for years, potentially leading to inappropriate treatment and the onset of early complications.

It is worth noting that Russian media outlets previously reported that Russia will soon see the emergence of innovative, locally made drugs for the treatment of type 2 diabetes and obesity.

what is your opinion on this news ?do let us know in the comments on tha comment box

 if you liked this news article please share on friends & family & don't forget to follow on website & social media


Post a Comment

Previous Post Next Post
Advertisement
Advertisement
Advertisement